Where have all the T cells gone? Mechanisms of immune evasion by tumors

被引：141

作者：

Finke, J

Ferrone, S

Frey, A

Mufson, A

Ochoa, A

机构：

[1] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA

[2] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA

[3] NYU, Dept Cell Biol, Ctr Med, New York, NY 10016 USA

[4] NCI, Canc Immunol Branch, Bethesda, MD 20892 USA

[5] Louisiana State Univ, Med Ctr, New Orleans, LA 70112 USA

来源：

IMMUNOLOGY TODAY | 1999年 / 20卷 / 04期

关键词：

D O I：

10.1016/S0167-5699(98)01435-2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The immune system of tumor-bearing patients and experimental animals is adversely affected by the tumor, even early in the course of disease. A recent meeting* focused on the mechanisms involved in this phenomenon and their implications for cancer immunotherapy.

引用

页码：158 / 160

页数：3

共 15 条

[1] FRANCO JL, 1995, CANCER RES, V55, P3840
[2] Fidelity of T cell activation through multistep T cell receptor ζ phosphorylation
Kersh, EN
Shaw, AS
Allen, PM
[J]. SCIENCE, 1998, 281 (5376) : 572 - 575
[3] T-CELLS FROM LATE TUMOR-BEARING MICE EXPRESS NORMAL LEVELS OF P56(LCK), P59(FYN), ZAP-70, AND CD3-ZETA DESPITE SUPPRESSED CYTOLYTIC ACTIVITY
LEVEY, DL
SRIVASTAVA, PK
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (04) : 1029 - 1036
[4] Impaired activation of NFΚB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor, IΚBα
Ling, WJ
Rayman, P
Uzzo, R
Clark, P
Kim, HJ
Tubbs, R
Novick, A
Bukowski, R
Hamilton, T
Finke, J
[J]. BLOOD, 1998, 92 (04) : 1334 - 1341
[5] Repression of interleukin-2 mRNA translation in primary human breast carcinoma tumor-infiltrating lymphocytes
Lopez, CB
Rao, TD
Feiner, H
Shapiro, R
Marks, JR
Frey, AB
[J]. CELLULAR IMMUNOLOGY, 1998, 190 (02) : 141 - 155
[6] Matsuda M, 1998, SCAND J IMMUNOL, V47, P254
[7] Costimulation, tolerance and ignorance of cytolytic T lymphocytes in immune responses to tumor antigens
Melero, I
Bach, N
Chen, LP
[J]. LIFE SCIENCES, 1997, 60 (23) : 2035 - 2041
[8] Petersson M, 1998, J IMMUNOL, V161, P2099
[9] Mechanisms responsible for signaling and functional defects
Reichert, TE
Rabinowich, H
Johnson, JT
Whiteside, TL
[J]. JOURNAL OF IMMUNOTHERAPY, 1998, 21 (04): : 295 - 306
[10] TAP off - Tumors on
Seliger, B
Maeurer, MJ
Ferrone, S
[J]. IMMUNOLOGY TODAY, 1997, 18 (06): : 292 - 299

← 1 2 →